Timothy N. Linnet,Stan W. Linnet,William K. Chan,Liang Xue
申请号：
US13163662
公开号：
US20120322813A1
申请日:
2011.06.17
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The teachings provided herein generally relate to compositions comprising a rutaecarpine derivative that activates CYP1A2 through enzyme induction. The compound can be used for treating caffeine toxicity, in some embodiments. Caffeine is just one example of a substrate that can be removed using the derivatives taught herein, and other examples, including theophylline, are provided herein.
